Clinical Report: Online Photo Diagnosis
Overview
This report discusses a case of a 12-year-old female patient who underwent orthokeratology (ortho-k) for myopia control, achieving 20/20 visual acuity after one month. The report highlights the importance of lens centration and ongoing research into factors affecting myopia progression.
Background
Myopia is a growing concern in pediatric ophthalmology, with increasing prevalence and potential long-term consequences on vision. Orthokeratology has emerged as a viable option for myopia control, particularly in children, by reshaping the cornea to reduce myopic progression. Understanding the factors influencing the effectiveness of ortho-k, including lens centration, is crucial for optimizing treatment outcomes.
Data Highlights
No numerical data was provided in the article.
Key Findings
- The patient achieved 20/20 visual acuity after one month of ortho-k treatment.
- Ortho-k lenses create myopic defocus, which can slow myopia progression.
- Decentration of ortho-k lenses may not significantly affect axial length changes in children.
- Future studies are needed to determine optimal defocus and lens design for effective myopia control.
- Combination therapies, such as ortho-k with 0.01% atropine, may enhance myopia control.
Clinical Implications
Detail specific monitoring strategies and combination therapies that may be beneficial.
Conclusion
This case underscores the effectiveness of ortho-k in myopia control while highlighting the need for further research on lens design and fitting practices to optimize patient outcomes.
References
- William Townsend, OD, FAAO, Contact Lens Spectrum, 2021 -- Online Photo Diagnosis
- IMI Interventions for Controlling Myopia Onset and Progression 2025 - Myopia Institute
- Value of adding 0.01% atropine with orthokeratology for myopia in children: an updated meta-analysis of randomized controlled trials - PubMed
- Safety and ocular health with an orthokeratology lens in Chinese myopes: a retrospective, multicentre study
- IMI Interventions for Controlling Myopia Onset and Progression 2025 - Myopia Institute
- Value of adding 0.01% atropine with orthokeratology for myopia in children: an updated meta-analysis of randomized controlled trials - PubMed
- Full article: Safety and ocular health with an orthokeratology lens in Chinese myopes: a retrospective, multicentre study
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.


